Can aggressive multiple myeloma go into and stay in remission

Q: Can aggressive multiple myeloma go into and stay in remission

Yes, aggressive multiple myeloma can achieve remission, even with high-risk features. What the Evidence Shows: Modern treatment approaches—particularly combinations of proteasome inhibitors, immunomodulatory drugs IMiDs, and monoclonal antibodies—have improved remission rates significantly, even for aggressive disease. According to NCCN Guidelines for Multiple Myeloma, patients with high-risk disease are typically treated with intensive multi-drug regimens designed to achieve deep remission mini

July 28, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case. No signup, answered right here.

or Upload your records for answers about your actual case

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
Last updated July 28, 2026. Informational only — not a substitute for your oncology team.

Can Aggressive Multiple Myeloma Go Into Remission?

Yes, aggressive multiple myeloma can achieve remission, even with high-risk features.

What the Evidence Shows:

Modern treatment approaches—particularly combinations of proteasome inhibitors, immunomodulatory drugs (IMiDs), and monoclonal antibodies—have improved remission rates significantly, even for aggressive disease.

According to NCCN Guidelines for Multiple Myeloma, patients with high-risk disease are typically treated with intensive multi-drug regimens designed to achieve deep remission (minimal residual disease-negative status when possible).

Remission Duration:

Some patients with aggressive myeloma achieve durable remissions lasting years
Others may have shorter remission periods before relapse
Maintenance therapy after initial treatment helps extend remission length
Individual outcomes vary based on specific genetic features and treatment response

Key Variables:

The likelihood and duration of remission depend on:

Specific high-risk cytogenetic features present
Treatment regimen used
How well the disease responds initially
Whether minimal residual disease (MRD) is achieved

Questions for your oncology team:

What is the expected remission duration for my specific risk profile?
What maintenance therapy do you recommend?
How will you monitor for early relapse?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation. No signup, answered right here.

or Upload your records for answers about your actual case

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →